Impact of measles vaccination strategies on vaccination rates in low-income and middle-income countries: a systematic review and meta-analysis
Open Access
- 10 February 2025
- journal article
- review article
- Published by BMJ in BMJ Global Health
- Vol. 10 (2) , e016647
Abstract
Introduction: While many interventions aim to raise measles vaccination coverage in low-income and middle-income countries (LMICs), their overall effectiveness and cost-effectiveness are unknown. We did a review to identify and synthesise scientific research that evaluated the impact and cost-effectiveness of measles vaccination strategies on measles vaccination coverage, timeliness, hospitalisation rates, and mortality. Methods: In this review, we searched for English-language articles published between 2012 and July 2023 in eight databases, including PubMed, ProQuest, MEDLINE (Ovid), Embase (Ovid), CINAHL, Scopus, Web of Science and the Cochrane Database of Systematic Reviews. We also included relevant grey literature sources. The review focused on studies evaluating the impact of vaccination strategies on vaccination-related outcomes in children under 5. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines throughout the process, we used Covidence software to manage most review activities. Two independent reviewers screened articles, assessed their quality using the Joanna Briggs Institute guidelines and extracted data using a predefined electronic tool. We predetermined measles vaccination coverage and timeliness as the primary outcomes, with hospitalisation and mortality as secondary outcomes. A random-effects model was employed for the meta-analysis. Results: We identified 44 articles, of which 14 were included in the meta-analysis. The meta-analysis indicated that vaccination-targeting interventions such as vaccination reminders, cash incentives, community engagement and health education activities increase measles vaccination coverage (RR 1.19, 95% CI 1.10 to 1.27). Our analysis also indicated that interventions such as vaccine reminders, educational programmes and incentives improved timely vaccination. Furthermore, we identified cost-effective strategies such as geographically informed microplanning, unrestricted vial opening, supplementary immunisation activities, community engagement, outreach programmes and financial incentives. Conclusion: Most of the identified vaccination interventions significantly improve measles vaccination coverage and timeliness in LMICs while remaining cost-effective. Tailoring these interventions to local contexts is crucial for maximising their effectiveness in protecting children from measles and its adverse consequences. PROSPERO registration number: CRD42023433125.Keywords
This publication has 65 references indexed in Scilit:
- Overall effect of a campaign with measles vaccine on the composite outcome mortality or hospital admission: A cluster-randomized trial among children aged 9-59 months in rural Guinea-BissauInternational Journal of Infectious Diseases, 2023
- Small mobile conditional cash transfers (mCCTs) of different amounts, schedules and design to improve routine childhood immunization coverage and timeliness of children aged 0-23 months in Pakistan: An open label multi-arm randomized controlled trialeClinicalMedicine, 2022
- Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: A single-centre open-label randomised controlled trialeClinicalMedicine, 2022
- Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of CongoVaccine, 2017
- A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participantsVaccine, 2017
- Effects of three interventions and determinants of full vaccination among children aged 12–59 months in Nyanza province, KenyaPublic Health, 2015
- Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysisSocial Science & Medicine, 2015
- Strategies for addressing vaccine hesitancy – A systematic reviewVaccine, 2015
- Measles, mumps, and rubella virus vaccine (M–M–R™II): A review of 32 years of clinical and postmarketing experienceVaccine, 2012
- A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profileVaccine, 2009